论文部分内容阅读
目的:观察克瘤胶囊治疗原发性肝癌疼痛的临床疗效。方法:将72例本病患者随机分为对照组和治疗组各36例,对照组采用西药治疗,治疗组口服克瘤胶囊。结果:治疗组总有效率为80.6%,对照组为55.6%,两组比较,P<0.05;且两组止痛持续时间比较差异也有统计学意义(P<0.05)。结论:克瘤胶囊治疗原发性肝癌疼痛疗效满意。
Objective: To observe the clinical curative effect of Kumu capsule on primary liver cancer pain. Methods: Seventy-two patients were randomly divided into control group and treatment group, with 36 cases in each group. The control group was treated with western medicine. The treatment group was treated with oral capsule. Results: The total effective rate was 80.6% in the treatment group and 55.6% in the control group, P <0.05. There was also significant difference in the duration of analgesia between the two groups (P <0.05). Conclusion: Kumu capsule treatment of primary liver cancer pain satisfaction.